Mind Medicine Australia FREE Webinar - A World-First: Transforming Mental Health Treatment with Psychedelic-Assisted Therapies

Don’t miss out – Get your tickets early!

Join this FREE WEBINAR presented by Psychiatrist Dr Stephen Proud and Mind Medicine Australia’s Executive Director, Tania de Jong AM.

A World-First: Transforming Mental Health Treatment with Psychedelic-Assisted Therapies

In this session, Psychiatrist Dr Stephen Proud and Mind Medicine Australia’s Executive Director, Tania de Jong AM, will provide an engaging update on psychedelic-assisted therapies. You’ll learn how these innovative treatments work, what’s required to deliver them safely and effectively, and how they can help people not responding to current therapies. The webinar will also cover the latest developments in Australia, including medicine supply, clinical rollouts, Authorised Prescriber support, and training opportunities for psychiatrists, doctors, and multidisciplinary clinicians.

EVENT DETAILS

DATE: 29th October 2025
TIME: 7:25pm (AEDT) for 7:30pm start, finishing at 8:30pm
DURATION: 60 minutes (incl Q&A)
LOCATION: Online – a link will be emailed to you with the viewing details

Learn how a movement for Healing Revolution was created in Australia and what is happening in the land down under right now!

Australia was the first country in the world to successfully apply to reschedule psilocybin and MDMA from Prohibited Substances to Controlled Medicine. The world-first rescheduling decision occurred in 2023. Since 2024 patients have been treated in clinical settings under the supervision of Authorised Prescribing psychiatrists and their clinical teams. Multiple clinics are emerging around the nation to meet the significant demand for these innovative therapies. With 1 in 4 Australians suffering from a mental illness and current treatments not helping the majority of those suffering, these innovative therapies are urgently needed.

Through the work of the Mind Medicine Australia charity led by social entrepreneurs and philanthropic pioneers, Tania de Jong AM and Peter Hunt AM, Australians suffering with depression and PTSD can now access psychedelic-assisted therapies.  MMA has developed the ecosystem for the use of these transformational treatments in Australia through world-leading training and professional development programs, education and awareness building, affordable medicine supplies, development of clinics and funding of innovative research and a world-first National Registry to collate real world evidence at Australian National University. Through MMA's work the Australian Government also invested AU15 million dollars for further research and trials in this rapidly emerging field. This is the largest grant awarded to this rapidly emerging field from any government.

Learn more about MMA's first six years here.

EVENT DETAILS

DATE: 29th October 2025
TIME: 7:25pm (AEDT) for 7:30pm start, finishing at 8:30pm
DURATION: 60 minutes (incl Q&A)
LOCATION: Online – a link will be emailed to you with the viewing details

This event is open to all Locum Life members and the broader clinical community. For clinicians wishing to get more information about joining Locum Life, please register here.

Please note that CPD Certificates will be supplied on request for a one-hour educational session.

At this event, we will also announce the new exclusive discount offer for Locum Life Clinicians to enrol for clinician training to complete the Certificate in Psychedelic Assisted Therapies.

ABOUT THE PRESENTER

Dr Stephen Proud
Psychiatrist

Stephen Proud is a psychiatrist in private practice in regional WA with 45 years’ experience in medicine and 25 years as a psychiatrist. He has 3 sons. He has worked as a GP in rural WA, Perth and rural Zululand South Africa. He has taught GPs and psychiatric registrars for many years in Perth. He has built and run two psychiatric hospitals, one in Perth and the other an innovative rural retreat where patients lived for a month to undergo extensive psychotherapy, meditation and community living.

He has a long interest in spirituality and psychotherapy, starting with psychedelics in the 1970s, going onto humanistic psychology in California, Vipassana, The Rajneesh Ashram in India and then experience with traditional healers and Sangomas in rural Zululand. He runs meditation and psychotherapy retreats and is Monash MAPS trained in MDMA assisted therapies. He is currently involved in an MDMA trial for PTSD in Perth.

Stephen extols cooperation and is open to all groups promoting safe and sensible Psychedelic-Assisted Therapies.

Tania de Jong AM   
Founder & Executive Director of Mind Medicine Australia

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 4 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.